Sichuan, China

Jia Du

This inventor holds 1 USPTO granted patent. Top assignees: Bioage Labs, Inc., Hitgen, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jia Du. Retrieved from https://idiyas.com/inventor/jia-du-gpjn9ij3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Spotlight on Inventor Jia Du: Innovations in Inflammation Research**

Introduction

Jia Du, located in Sichuan, China, is an innovative inventor recognized for his contributions to the field of inflammation research. With a strong focus on developing therapeutic solutions, he has made significant strides, including the advancement of a crucial patent that targets age-related inflammatory disorders.

Latest Patents

Jia Du holds a patent for "Inhibitors of NLRP3 Inflammasome." This patent involves compounds that act as inhibitors for NLRP3 inflammasomes. The innovation has significant implications for treating various disorders associated with inflammation and the aging process, including hearing loss and other diseases linked to aging.

Career Highlights

Throughout his career, Jia Du has been associated with notable companies including BioAge Labs, Inc. and Hitgen, Inc. His expertise has contributed to the technological advancements and research developments in his respective fields.

Collaborations

Collaboration plays a pivotal role in innovation. Jia Du has worked alongside esteemed colleagues such as George D. Hartman and Xu He, exchanging ideas and fostering a productive research environment that encourages creativity and breakthrough solutions.

Conclusion

Jia Du exemplifies the dedication of inventors who strive to enhance human health through innovative research and solutions. His work on inhibitors of NLRP3 inflammasome is a testament to his commitment to addressing the challenges associated with aging and inflammation, marking him as a significant figure in the world of biomedical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…